secwatch.observer — SEC 8-K summary
======================================

Issuer:     Hoth Therapeutics, Inc. (HOTH)
CIK:        0001711786
Form:       8-K
Filed at:   2022-01-21T23:59:59+00:00
Accession:  0001213900-22-003061
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Hoth Therapeutics director Vadim Mats resigns from Board effective Jan 31, 2022
-------------------------------------------------------------------------------

- Director Vadim Mats informed the Company he will resign from the Board and its compensation and nominating/corporate governance committees.
- Resignation effective January 31, 2022; not due to any disagreement with the Company's operations, policies, management, or Board.
- No replacement has been announced; Board size will decrease by one member.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1711786/000121390022003061/0001213900-22-003061-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1711786/000121390022003061/ea154246-8k_hoththerap.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-003061

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer